CULLINAN THERAPEUTICS, INC. (CGEM) Operating cash flow 2020–2025
CULLINAN THERAPEUTICS, INC. (CGEM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$175.8MFY2025 · since FY2020: -$29.8M → -$175.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$175.8M | -21.0% |
| FY2024 | -$145.3M | -8.2% |
| FY2023 | -$134.3M | -6.0% |
| FY2022 | -$126.7M | -191.6% |
| FY2021 | -$43.4M | -45.9% |
| FY2020 | -$29.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice